Skip to content
‹ Back to IndustriesHealthcare

Minimally Invasive Robots Are Making Their Presence Known Across Industries

Fear of spiders and other bugs is among the 10 most common phobias, according to mental health research. But sometimes these pesky critters can help us, right? Consider the honeybee, for example. Now there is a new bug on the scene. Rolls Royce has created a prototype of a tiny insect-inspired robot to help build…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

·
Share

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

Fear of spiders and other bugs is among the 10 most common phobias, according to mental health research. But sometimes these pesky critters can help us, right? Consider the honeybee, for example. Now there is a new bug on the scene. Rolls Royce has created a prototype of a tiny insect-inspired robot to help build and maintain the engines in its luxury automobiles.

The little bug-like machines (the company is pushing for even smaller models) can get into crevices too small for human hands, perform diagnostics, and even do repairs. In addition, the Rolls Royce of medicine, Vanderbilt University Hospital, is using bots of all sizes to minimize the challenges of their already minimally invasive surgical procedures, with the end goal of safer surgeries and easier recoveries.

These robotic devices can go where humans cannot, and as such are having a huge impact on the medical and automotive industries. The precision of such devices is key to their implementation across all industries and Rolls Royce and Vanderbilt are proving that this type of technology is close to being widespread. If prestigious organizations such as these are investing in robot research, we can assume that their use will spread beyond just transportation and medicine.

While some would say we are on the precipice of the robot revolution, a perusal of the latest reports in technology reveals that we are in the dead center of such a revolution. Technologies from engineering to genetics to kinesiology are playing a role in these innovations. Audiologists are even stepping in, with cutting edge tech to improve the listening skills of these automatons.

With such a diversity of technologies involved, and with robotics impacting industries from medicine and education to entertainment and manufacturing, it’s clear that robots, even the creepy-crawly kind, are here to stay.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

QinFlow's new pressure bag device skips scheduled calibration and preventive maintenance

QinFlow's new pressure bag device skips scheduled calibration and preventive maintenance

QinFlow's PressSure is a battery-powered device that holds standard pressure bags at one of three fixed preset pressures during blood or IV fluid infusions.

  • 01The claims so far are design claims and an award shortlist; the signal worth watching is whether QinFlow or early adopters publish in-service data on reinflation time saved.

Oct 1, 2026

BedConnect’s Lindsey Joseph on matching post-acute care to patient needs

BedConnect’s Lindsey Joseph on matching post-acute care to patient needs

On I Don’t Care, BedConnect founder Lindsey Joseph and Kevin Stevenson discuss the limits of broad post-acute referrals. Their proposal is to match clinical needs, payer coverage and available beds before presenting options. CMS guidance and AHRQ discharge resources provide independent context; they do not establish BedConnect’s clinical outcomes.

  • 01BedConnect proposes matching clinical needs, payer coverage and bed availability before presenting post-acute options; this is the company’s approach, not independently validated outcome evidence.
  • 02CMS discharge-planning guidance emphasizes patient goals, treatment preferences and relevant provider quality and resource-use data.
  • 03Readmission comparisons need a defined patient group, time window and source; the interview’s roughly one-quarter/fourteen-day estimate has not been independently verified.

Sep 29, 2026

Rock Health: $7.4B went into digital health in H1 2026, and 20 rounds took 45%

Rock Health: $7.4B went into digital health in H1 2026, and 20 rounds took 45%

Rock Health: U.S. digital health startups raised $7.4 billion across 244 deals in H1 2026, up from $6.4 billion on 245 deals in H1 2025. The rebound is concentrated. Nineteen companies raised 20 $100 million-plus rounds that captured 45% of capital.

  • 01In H1 2026, 19 companies raised 20 mega-deals of $100 million or more, representing 45% of all capital invested, according to Rock Health.
  • 02According to Rock Health, the firm stopped labeling startups as “AI-enabled,” saying the technology is now too widespread for the label to be meaningful.

Sep 24, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512